ReviewReproductive sciences (Thousand Oaks, Calif.)2026
Sperm Testing in Assisted Reproductive Technology: Diagnosis and Outcome Prediction.
Review in Reproductive sciences (Thousand Oaks, Calif.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Infertility is a major global reproductive health challenge with significant social consequences, affecting an estimated 1 in 6 couples worldwide. Declining sperm quality represents a key contributing factor, making sperm analysis essential for diagnosing male infertility. Beyond conventional semen analysis, advanced assessments such as sperm DNA fragmentation testing and acrosome function evaluation have become standard diagnostic tools. Meanwhile, new technologies-such as 3D sperm imaging, high-precision microscopy, and genetic sequencing-are transforming sperm evaluation by analyzing movement, structure, function, and genetics in detail. These technological advancements enable two synergistic clinical improvements: (1) Deeper mechanistic understanding of sperm physiology via behavioral observation and molecular characterization, and (2) Enhanced sperm selection for assisted reproductive technologies (ART) through precision screening. The integration of interdisciplinary approaches-combining andrology, bioengineering, and computational biology-promises to accelerate the translation of novel sperm analysis platforms into clinical practice. This paradigm shift ultimately aims to elevate ART success rates while establishing evidence-based diagnostic frameworks for male infertility management.
Indexed as
Identifiers
41680577What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.